A panel of cardiology pharmacists discussed the diagnostic red flags, evolving treatment landscape, and expanding pharmacist role central to identifying and managing ATTR-CM.
|Articles|April 19, 2017
- April 2017 Respiratory Health
- Volume 83
- Issue 4
Can You Read These Rxs? (April 2017)
These are our stumpers for April.
Advertisement
SEE THE ANSWER ON PAGE 2.
ANSWER
R x 1 : Luvox 50 mg, #30, one tablet once a day; Buspar 10 mg, #60, one tablet twice a day; Klonopin 0.5 mg, #12, one tablet daily.
SEE THE NEXT PRESCRIPTION ON PAGE 3.
R x 2 : Bactrim DS, #14, one tablet by mouth twice a day.
Articles in this issue
over 9 years ago
Epinephrine: Optimizing Its Versatilityover 9 years ago
Metformin and Organic Cation Transporter Interactionsover 9 years ago
The Impact of PCSK9 Inhibition in Dyslipidemia Managementover 9 years ago
HIV Infection: The Future of Therapyover 9 years ago
Self-Care for Respiratory Disordersover 9 years ago
Smoking Cessation: Getting Patients on Boardover 9 years ago
Yospralaover 9 years ago
"Use as Directed" Is a Source of ConfusionAdvertisement
Related to this article
Weight-based norepinephrine dosing did not improve time to goal MAP, and median dose was similar compared with non–weight-based dosing in patients with septic shock.
The panelists emphasized that selecting a therapy is only one step toward improving outcomes for patients with heart failure.
Pharmacists can educate patients about staying up to date on immunizations and discuss fall prevention strategies.
Pharmacists describe their experiences using DEA certificates for controlled substance prescribing in different practice settings, as well as barriers and opportunities for future expansion.
Professional membership and experienced mentor leadership offer new pharmacy technicians a dual advantage, serving as a comprehensive training accelerator.
A biologic stewardship framework can enhance consistency, safety, and sustainability of biologic use in health systems.
Artificial intelligence (AI) transforms a chaotic, reactive process into an adaptive, proactive system that improves workflow and patient safety.
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Data Reshapes Nonstatin Lipid Therapy Choices
2
Eight Names, One Drug: Why Adalimumab Biosimilars Are Creating Real Confusion at the Counter
3
Etentamig Reduces Risk of Progression or Death by 60% in Relapsed/Refractory Multiple Myeloma
4
Medication Management: A Crucial Part of Healthy Aging
5